175 related articles for article (PubMed ID: 35832559)
1. Vitamin C Deficiency in Patients With Acute Myeloid Leukemia.
Ottone T; Faraoni I; Fucci G; Divona M; Travaglini S; De Bellis E; Marchesi F; Angelini DF; Palmieri R; Gurnari C; Giansanti M; Nardozza AM; Montesano F; Fabiani E; Lindfors Rossi EL; Cerretti R; Cicconi L; De Bardi M; Catanoso ML; Battistini L; Massoud R; Venditti A; Voso MT
Front Oncol; 2022; 12():890344. PubMed ID: 35832559
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
3. Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration.
Liu J; Hong J; Han H; Park J; Kim D; Park H; Ko M; Koh Y; Shin DY; Yoon SS
Br J Cancer; 2020 May; 122(10):1445-1452. PubMed ID: 32203209
[TBL] [Abstract][Full Text] [Related]
4. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract][Full Text] [Related]
5. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
[No Abstract] [Full Text] [Related]
6. Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.
Zhou Y; Moon A; Hoyle E; Fromm JR; Chen X; Soma L; Salipante SJ; Wood BL; Wu D
Cytometry B Clin Cytom; 2019 Jan; 96(1):67-72. PubMed ID: 30417521
[TBL] [Abstract][Full Text] [Related]
7. Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia.
Chen X; Othus M; Wood BL; Walter RB; Becker PS; Percival ME; Abkowitz JL; Appelbaum FR; Estey EH
Leuk Lymphoma; 2021 May; 62(5):1226-1233. PubMed ID: 33345655
[TBL] [Abstract][Full Text] [Related]
8. Transforming Acute Myeloid Leukemia Treatment Through Next-Generation Sequencing: A Single-Center Experience.
Devarkonda V; Akabane H
Cureus; 2023 Sep; 15(9):e45917. PubMed ID: 37885525
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
10. Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
Gyurkocza B; Gutman J; Nemecek ER; Bar M; Milano F; Ramakrishnan A; Scott B; Fang M; Wood B; Pagel JM; Baumgart J; Delaney C; Maziarz RT; Sandmaier BM; Estey EH; Appelbaum FR; Storer BE; Deeg HJ
Biol Blood Marrow Transplant; 2014 Apr; 20(4):549-55. PubMed ID: 24440648
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
12. Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
Jabbour E; Garcia-Manero G; Cortes J; Ravandi F; Plunkett W; Gandhi V; Faderl S; O'Brien S; Borthakur G; Kadia T; Burger J; Konopleva M; Brandt M; Huang X; Kantarjian H
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):244-51. PubMed ID: 22534616
[TBL] [Abstract][Full Text] [Related]
13. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
14. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
[TBL] [Abstract][Full Text] [Related]
15. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
[TBL] [Abstract][Full Text] [Related]
16. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.
Estey E; Thall P; Beran M; Kantarjian H; Pierce S; Keating M
Blood; 1997 Oct; 90(8):2969-77. PubMed ID: 9376577
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem.
Latagliata R; Petti MC; Fenu S; Mancini M; Spiriti MA; Breccia M; Brunetti GA; Avvisati G; Lo Coco F; Mandelli F
Blood; 2002 Feb; 99(3):822-4. PubMed ID: 11806982
[TBL] [Abstract][Full Text] [Related]
18.
Giudice V; Gorrese M; Vitolo R; Bertolini A; Marcucci R; Serio B; Guariglia R; Ferrara I; Pepe R; D'Alto F; Izzo B; Pedicini A; Montuori N; Langella M; Selleri C
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33917307
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
20. Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG).
Wanitpongpun C; Utchariyaprasit E; Owattanapanich W; Tantiworawit A; Rattarittamrong E; Niparuck P; Puavilai T; Julamanee J; Saelue P; Chanswangphuwana C; Polprasert C; Nakhakes C; Limvorapitak W; Kanitsap N; Prayongratana K; Sriswasdi C
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e635-e643. PubMed ID: 33926829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
